Je veux savoir à propos de…

lotter on DSK11XQN23PROD with NOTICES1

Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices with AI/AN tribal nations and to improve the health of AI/AN tribal nations by pursuing goals that include assisting in eliminating the health disparities faced by AI/AN tribal nations; ensuring that access to critical health and human services and public health services is maximized to advance or enhance the social, physical, and economic status of AI/AN people; and promoting health equity for all Indian people and communities. To advance these goals, CDC/ATSDR conducts government-to-government consultations with elected tribal officials or their authorized representatives. Consultation is an enhanced form of communication that emphasizes trust, respect, and shared responsibility. It is an open and free exchange of information and opinion among parties that leads to mutual understanding.
Matters To Be Considered: CDC/
ATSDR is hosting this meeting to hold a consultation with federally recognized tribal nations to receive input and guidance on improving the current CDC/ATSDR Tribal Consultation Policy.
CDC/ATSDR is seeking feedback on how the agency can improve its policies and practices to better engage with Indian Country through meaningful consultation. This feedback will be used to edit the current CDCs Consultation Policy. The Tribal consultation session will provide opportunities for elected AI/AN tribal officials to speak openly about the public health issues affecting their tribal nations. This consultation session is virtual and open to the public.
Elected tribal officials can find guidance to assist in developing tribal testimony for CDC/ATSDR at https www.cdc.gov/
tribal/documents/consultation/TribalTestimony-Guidance.pdf. Please submit tribal testimony on official tribal letterhead.
Based on the number of elected tribal officials giving testimony and the time available, it may be necessary to limit the time for each presenter. We will adjourn tribal consultation meetings early if all attendees who requested to provide oral testimony in advance of and during the consultation have delivered their comments. Agenda items are subject to change as priorities dictate.
Additional information about CDC/
ATSDRs Tribal Consultation Policy can be found at https www.cdc.gov/tribal/
consultation-support/tribalconsultation/policy.html.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal
VerDate Sep<11>2014

17:12 Jul 01, 2021

Jkt 253001

Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
FR Doc. 202114205 Filed 7121; 8:45 am BILLING CODE 416318P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and Prevention Docket No. CDC20210034

Advisory Committee on Immunization Practices ACIP; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Advisory Committee on Immunization Practices ACIP; June 23, 2021, from 10:00 a.m. to 5:00 p.m., EDT times subject to change; June 24, 2021, from 10:30 a.m. to 5:10 p.m., EDT
times subject to change; and June 25, 2021, from 10:00 a.m. to 12:20 p.m., EDT times subject to change, in the amended FRN. The virtual meeting was published in the Federal Register on Wednesday, June 23, 2021, Volume 86, Number 118, pages 3293332934.
The virtual meeting is being amended to update the meeting times on June 23
25, 2021 times subject to change and matters to be considered and should read as follows:
SUMMARY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention CDC, announces the following meeting of the Advisory Committee on Immunization Practices ACIP. This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: http www.cdc.gov/
vaccines/acip/index.html.
DATES: The meeting will be held on June 23, 2021, from 11:00 a.m. to 4:00 p.m., EDT times subject to change; June 24, 2021, from 10:00 a.m. to 5:15 p.m., EDT
times subject to change; and June 25, 2021, from 10:00 a.m. to 1:00 p.m., EDT
times subject to change. Written comments must be received on or before June 25, 2021.
A notice of this ACIP meeting has also been posted on CDCs ACIP website at:
http www.cdc.gov/vaccines/acip/

PO 00000

Frm 00041

Fmt 4703

Sfmt 9990

35299

index.html. In addition, CDC has sent notice of this ACIP meeting by email to those who subscribe to receive email updates about ACIP.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, MSH248, Atlanta, GA 30329
4027; Telephone: 4046398367; Email:
ACIP@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children VFC program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC
immunization schedules must be covered by applicable health plans.
Matters To Be Considered: The agenda will include discussions on COVID19, dengue vaccine, herpes zoster vaccines, influenza vaccines, pneumococcal vaccine, and rabies vaccine.
Recommendation votes on dengue vaccine, influenza vaccines and rabies vaccine are scheduled. Vaccines for Children VFC votes on dengue vaccine and influenza vaccines are scheduled.
Agenda items are subject to change as priorities dictate. For more information on the meeting agenda visit https
www.cdc.gov/vaccines/acip/meetings/
meetings-info.html.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
FR Doc. 202114203 Filed 7121; 8:45 am BILLING CODE 416318P

E:FRFM02JYN1.SGM

02JYN1